Stroncek DF - Search Results

1

Analysis of vaccine-induced T cells in humans with cancer.

Slezak SL, Worschech A, Wang E, Stroncek DF, Marincola FM. Slezak SL, et al. Among authors: stroncek df. Adv Exp Med Biol. 2010;684:178-88. doi: 10.1007/978-1-4419-6451-9_14. Adv Exp Med Biol. 2010. PMID: 20795549 Free PMC article.

2

High-resolution HLA-A*0201 subtyping using directed heteroduplex analysis.

Kicklighter EJ, Lee KH, Barracchini KC, Bettinotti M, Norris R, Simonis TB, Stroncek D, Marincola FM. Kicklighter EJ, et al. J Immunother. 1999 May;22(3):219-28. doi: 10.1097/00002371-199905000-00004. J Immunother. 1999. PMID: 10335481

3

Frequency of human leukocyte antigen-A 24 alleles in patients with melanoma determined by human leukocyte antigen-A sequence-based typing.

Bettinotti MP, Norris RD, Hackett JA, Thompson CO, Simonis TB, Stroncek D, Marincola FM. Bettinotti MP, et al. J Immunother. 2000 Mar-Apr;23(2):282-7. doi: 10.1097/00002371-200003000-00013. J Immunother. 2000. PMID: 10746555

4

Detection of HLA antibodies by using flow cytometry and latex beads coated with HLA antigens.

Moses LA, Stroncek DF, Cipolone KM, Marincola FM. Moses LA, et al. Among authors: stroncek df. Transfusion. 2000 Jul;40(7):861-6. doi: 10.1046/j.1537-2995.2000.40070861.x. Transfusion. 2000. PMID: 10924616

5

High throughput HLA sequence-based typing (SBT) utilizing the ABI Prism 3700 DNA Analyzer.

Adams SD, Barracchini KC, Simonis TB, Stroncek D, Marincola FM. Adams SD, et al. Tumori. 2001 Mar-Apr;87(2):S40-3. Tumori. 2001. PMID: 11401225

6

Laser scanning cytometry evaluation of MART-1, gp100, and HLA-A2 expression in melanoma metastases.

Mocellin S, Fetsch P, Abati A, Phan GQ, Wang E, Provenzano M, Stroncek D, Rosenberg SA, Marincola FM. Mocellin S, et al. J Immunother. 2001 Nov-Dec;24(6):447-58. doi: 10.1097/00002371-200111000-00002. J Immunother. 2001. PMID: 11759068

7

Identification of immune dominant cytomegalovirus epitopes using quantitative real-time polymerase chain reactions to measure interferon-gamma production by peptide-stimulated peripheral blood mononuclear cells.

Provenzano M, Mocellin S, Bettinotti M, Preuss J, Monsurrò V, Marincola FM, Stroncek D. Provenzano M, et al. J Immunother. 2002 Jul-Aug;25(4):342-51. doi: 10.1097/00002371-200207000-00006. J Immunother. 2002. PMID: 12142557

8

The matrix protein pp65(341-350): a peptide that induces ex vivo stimulation and in vitro expansion of CMV-specific CD8+ T cells in subjects bearing either HLA-A*2402 or A*0101 allele.

Provenzano M, Lim JB, Mocellin S, Monsurro V, Bettinotti M, Marincola FM, Stroncek DF. Provenzano M, et al. Among authors: stroncek df. Transfusion. 2003 Nov;43(11):1567-74. doi: 10.1046/j.1537-2995.2003.00564.x. Transfusion. 2003. PMID: 14617317

9

HLA class I and II genotype of the NCI-60 cell lines.

Adams S, Robbins FM, Chen D, Wagage D, Holbeck SL, Morse HC 3rd, Stroncek D, Marincola FM. Adams S, et al. J Transl Med. 2005 Mar 4;3(1):11. doi: 10.1186/1479-5876-3-11. J Transl Med. 2005. PMID: 15748285 Free PMC article.

10

Advancing cancer biotherapy with proteomics.

Stroncek DF, Burns C, Martin BM, Rossi L, Marincola FM, Panelli MC. Stroncek DF, et al. J Immunother. 2005 May-Jun;28(3):183-92. doi: 10.1097/01.cji.0000162781.78384.95. J Immunother. 2005. PMID: 15838374 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

411 results

Search Page

Filters